These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7074796)

  • 1. Drug-induced conditioning in congestive heart failure.
    Leier CV; Huss P; Lewis RP; Unverferth DV
    Circulation; 1982 Jun; 65(7):1382-7. PubMed ID: 7074796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
    Liang CS; Sherman LG; Doherty JU; Wellington K; Lee VW; Hood WB
    Circulation; 1984 Jan; 69(1):113-9. PubMed ID: 6357536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
    Applefeld MM; Newman KA; Grove WR; Sutton FJ; Roffman DS; Reed WP; Linberg SE
    Am J Cardiol; 1983 Feb; 51(3):455-8. PubMed ID: 6823859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.
    Krell MJ; Kline EM; Bates ER; Hodgson JM; Dilworth LR; Laufer N; Vogel RA; Pitt B
    Am Heart J; 1986 Oct; 112(4):787-91. PubMed ID: 3766379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to dobutamine after a 72 hour continuous infusion.
    Unverferth DA; Blanford M; Kates RE; Leier CV
    Am J Med; 1980 Aug; 69(2):262-6. PubMed ID: 7405947
    [No Abstract]   [Full Text] [Related]  

  • 7. Dobutamine in left heart failure after acute myocardial infarction.
    Rehnqvist N; Lundman T
    Acta Med Scand; 1979; 206(4):299-302. PubMed ID: 506801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
    Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR
    Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
    Berger M; McSherry CK
    Chest; 1985 Aug; 88(2):295-6. PubMed ID: 4017685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.
    Liang C; Tuttle RR; Hood WB; Gavras H
    J Clin Invest; 1979 Aug; 64(2):613-9. PubMed ID: 457872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of dobutamine in severe congestive heart failure.
    Andy JJ; Curry CL; Ali N; Mehrotra PP
    Am Heart J; 1977 Aug; 94(2):175-82. PubMed ID: 878985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intermittent dobutamine infusion in congestive heart failure.
    Mauro VF; Mauro LS
    Drug Intell Clin Pharm; 1986 Dec; 20(12):919-24. PubMed ID: 3545732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Loeb HS; Bredakis J; Gunner RM
    Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
    Maskin CS; Forman R; Sonnenblick EH; Frishman WH; LeJemtel TH
    Am J Cardiol; 1983 Jan; 51(1):177-82. PubMed ID: 6849256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.